Andere talen Ningbo Menovo Pharmaceutical Co., Ltd.

Aandelen

603538

CNE100002Y25

slotkoers Shanghai S.E. Andere beurzen 00:00:00 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,19 ^CNY	+2,83%		+6,77%	-25,78%

29/04	Ningbo Menovo Pharmaceutical Co, Ltd. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
29/04	Ningbo Menovo Pharmaceutical Co, Ltd. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Menovo Pharmaceutical Unit Gets Approval to Register Vildagliptin Tablets	23/04
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on July 20, 2023	16/04
Menovo Pharma's Unit Gets Nod to Market Clopidogrel Hydrogen Sulfate Tablets	06/03
Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3%	04/03
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) dropped from S&P Global BMI Index	18/12
Ningbo Menovo Pharma Registers Seizure Drug in China	05/12
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Menovo Pharmaceutical Unit's Rosuvastatin Calcium Passes Drug Regulator's Technical Review	11-10-23
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) added to S&P Global BMI Index	18-09-23
Ningbo Menovo Pharma Registers Blood Pressure Drug	06-09-23
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 652 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors	20-07-23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 651.999948 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors.	20-07-23
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive funding from Ningbo Menovo Holding Group Co., Ltd.	20-07-23
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on August 15, 2022	20-07-23
Menovo Pharmaceutical's Unit Gets Nod to Own Olmesartan Medoxomil Tablets	14-07-23
Menovo Pharma Gets European Certification for Diet Drug	08-06-23
Menovo Pharma Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets	25-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ningbo Menovo Pharmaceutical Co., Ltd.

Aandelen

603538

CNE100002Y25

Andere talen

Filters